USD 0.89
(7.23%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -21.92 Million USD | 61.4% |
2022 | -56.8 Million USD | -77.44% |
2021 | -32.01 Million USD | -135.53% |
2020 | 90.08 Million USD | 52.59% |
2019 | 59.03 Million USD | 10.11% |
2018 | 53.61 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -4.3 Million USD | -267.51% |
2024 Q3 | 1.12 Million USD | -83.6% |
2024 Q2 | 6.88 Million USD | 260.14% |
2023 Q4 | 2.56 Million USD | 235.99% |
2023 FY | -21.92 Million USD | 61.4% |
2023 Q3 | 764 Thousand USD | 106.18% |
2023 Q2 | -12.36 Million USD | -5.43% |
2023 Q1 | -11.72 Million USD | -41.91% |
2022 Q1 | -20.33 Million USD | -67.91% |
2022 Q2 | -12.03 Million USD | 40.84% |
2022 FY | -56.8 Million USD | -77.44% |
2022 Q4 | -8.26 Million USD | 37.36% |
2022 Q3 | -13.18 Million USD | -9.62% |
2021 FY | -32.01 Million USD | -135.53% |
2021 Q4 | -12.11 Million USD | -102.38% |
2021 Q3 | 509.26 Million USD | 5520.36% |
2021 Q2 | 9.06 Million USD | 233.54% |
2021 Q1 | -6.78 Million USD | -208.55% |
2020 Q4 | -2.19 Million USD | -189.06% |
2020 Q2 | -13.65 Million USD | -209.49% |
2020 FY | 90.08 Million USD | 52.59% |
2020 Q1 | 12.46 Million USD | 0.0% |
2020 Q3 | 2.46 Million USD | 118.09% |
2019 FY | 59.03 Million USD | 10.11% |
2018 FY | 53.61 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Oncology Network, Inc. | -49.15 Million USD | 55.393% |
Assure Holdings Corp. | -20.08 Million USD | -9.182% |
Novo Integrated Sciences, Inc. | -8.55 Million USD | -156.35% |
Panamera Holdings Corporation | -7.12 Million USD | -207.92% |